NEWSROOM
Vocodia Announces Founder and Management Team Investments in Company IPO
CHICAGO, March 26, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was completed on February 22, 2024. Brian Podolak, Co-Founder, Chief Executive Officer and Director of Vocodia, invested $400,000 through the purchase of 94,117 units of the IPO. James Sposato, Co-Founder, Chief...
PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024
New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...
Avant Technologies to Build First AI-Focused Data Center in Milwaukee
LAS VEGAS, NEVADA, March 25, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in creating and developing innovative and advanced AI infrastructure solutions, today announced plans for the Company’s first Avant-branded micro data center, which will be specifically designed for private cloud companies in the booming AI and big data sectors. Avant’s initial data center is set to be built in Milwaukee,...
Nutra Pharma Corp. Reaches Settlement with SEC
Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 - Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean...
American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call
Conference Call on Thursday, March 28th at 12:00 pm ET / 9:00 am PT SAN FRANCISCO, CA, March 22, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its fourth quarter 2023 financial results on Thursday, March 28th at 12:00 pm ET / 9:00 am PT. The fourth quarter...
TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture
Cheyenne, WY, March 21, 2024 - TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health Sciences Inc., has entered into a Joint Venture Agreement with Better Health Sciences For Pets Corp., otherwise known as the Better Pets brand. This Joint Venture agreement outlines a strategic collaboration focused on marketing and distributing new key products from Better Pets. Under the terms of the agreement, TransGlobal Assets...
SPZI: JP 3E Holdings, Inc. Retains Accell Audit & Compliance, PA to Audit the Financial Statements
JP 3E Holdings, Inc., formerly Spooz Inc., will become a Fully Reporting Company, Retaining Accell Audit & Compliance, PA in pursuit of Uplisting Clearwater, FL., March 21, 2024 - JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI), retains Accell Audit & Compliance, PA to audit the company’s financials to become an SEC Fully Reporting company. This is the first step toward achieving its goal of uplisting first to the OTCQB. Accell is registered with the Public Company Accounting...
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
Conference Call on Monday, April 1st, at 4:30 pm ET POMPANO BEACH, FLORIDA, March 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its fourth quarter 2023 financial results post-market Monday, April 01, 2024. BioStem will host a conference call and webcast at 4:30 pm ET on Monday, April 01, 2024....
Avant Technologies Enters into Negotiations to Acquire Key Player in Healthcare Data Interoperability Services
LAS VEGAS, NEVADA, March 20, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in developing innovative and advanced AI and AI infrastructure solutions, today announced that it has entered into negotiations to acquire a privately held healthcare technology and data integration services firm in a cash-and-stock transaction valued at approximately $2 million. Financial and Strategic Benefits of this...
Clubhouse Media Group, Inc. Announces Rollout of Creator Video Discovery Page on HoneyDrip.com
LOS ANGELES, March 20, 2024 - Clubhouse Media Group, Inc., (OTC: CMGR) ("CMGR"), a social media firm, today announced that HoneyDrip.com will soon be adding a video page that will give fans visibility and the ability to subscribe to various new creator pages across HoneyDrip. Typically, fans follow their favorite social media creators over to our site. However, the enhancement will give fans exposure to many other creators so they can explore the site and see more of what the platform has...